Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001990032 | SCV002232657 | pathogenic | MEGF8-related Carpenter syndrome | 2021-11-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with MEGF8-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg419*) in the MEGF8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MEGF8 are known to be pathogenic (PMID: 23063620). |
Revvity Omics, |
RCV001990032 | SCV003808777 | uncertain significance | MEGF8-related Carpenter syndrome | 2021-10-01 | criteria provided, single submitter | clinical testing |